Key result
The Norwegian version of the CROQ-PCI demonstrated good acceptability, reliability, and validity among 171 patients (66% response rate) who had undergone percutaneous coronary intervention.
Why the study?
Is the Norwegian version of the Coronary Revascularisation Outcome Questionnaire (CROQ-PCI) a valid and reliable tool for assessing health-related quality of life in patients who have undergone PCI?
Observational (n=171)
Is the Norwegian version of the Coronary Revascularisation Outcome Questionnaire (CROQ-PCI) a valid and reliable tool for assessing health-related quality of life in patients who have undergone PCI?
The Norwegian version of the CROQ-PCI is a reliable and valid patient-reported outcome measure for assessing health-related quality of life in patients after PCI.
Norwegian CROQ-PCI is reliable and valid; leaves open routine clinical use pending responsiveness confirmation.
BACKGROUND: Health-related quality of life (HRQOL) questionnaires are increasingly used as outcome measures in research and clinical practice to assess treatment effectiveness in coronary heart disease (CHD) alongside traditional outcome measures. The Coronary Revascularisation Outcome Questionnaire (CROQ) is a patient-reported outcome measure (PROM) to evaluate health outcomes and HRQOL before and after coronary artery bypass grafting surgery (CABG) and percutaneous coronary intervention (PCI). AIM: To translate the CROQ-PCI from English into Norwegian and test its psychometric properties. METHODS: Independent forward and backward translation was done following international guidelines. The CROQ was then pretested with both healthcare professionals and patients before the psychometric properties were field tested in a sample of patients who had undergone PCI. Psychometric testing included an evaluation of: acceptability; tests of scaling assumptions; reliability; content validity; construct validity based on within-scale analyses; and construct validity based on comparisons with external measures. RESULTS: 171 of 258 (66%) invited patients participated. The CROQ was acceptable to patients (low proportion of missing data and good response rate), reliable (good internal consistency and test-retest reliability for all scales), had good content validity (reported by both patients and healthcare professionals) and good construct validity (convergent validity with the SF-12 and Seattle Angina Questionnaire, known groups validity and factor analysis). CONCLUSION: The Norwegian version of CROQ-PCI is a reliable and valid PROM for assessing HRQOL in CHD patients. Further testing of its responsiveness and ability to detect change is needed before recommending its use in Norwegian clinical practice and research.
No takes yet. Share an insight, caveat, or question.
Lillevik et al. (2017) conducted an observational in Coronary heart disease post-PCI (n=171). Norwegian version of the Coronary Revascularisation Outcome Questionnaire (CROQ-PCI) was evaluated on Psychometric properties including acceptability, reliability, content validity, and construct validity. The Norwegian version of the CROQ-PCI demonstrated good acceptability, reliability, and validity among 171 patients (66% response rate) who had undergone percutaneous coronary intervention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: